| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b17d27f769f632ff9f790084ab720c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07720d7b0f9ed3821684697256db8a40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d320f57873cfd49575420b4b468272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2442088e7eead359ed56a31f73962b1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e601c42ec6ee62392c3275159598015e |
| publicationDate |
2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11517564-B2 |
| titleOfInvention |
Methods of treatment for cystic fibrosis |
| abstract |
Compound I of the formula (I) and/or pharmaceutically acceptable salt(s) of Compound I comprised in a pharmaceutical composition and methods of using the same to treat cystic fibrosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022257564-A1 |
| priorityDate |
2017-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |